Adult respiratory outcomes of extreme preterm birth. A regional cohort study

Maria Vollsæter1, Hege H Clemm, Emma Satrell

  • 11 Department of Clinical Science, Section for Pediatrics, University of Bergen, Bergen, Norway.

Insights

Young adults born extremely prematurely show normal lung function but increased airway responsiveness. Ongoing pulmonary monitoring is recommended for this population.

Area of Science:

  • Pulmonary Medicine
  • Neonatalogy
  • Pediatric Pulmonology

Background:

  • Long-term respiratory outcomes after extremely preterm birth (gestational age ≤28 weeks or birth weight ≤1,000 g) remain largely unknown.
  • Understanding adult lung function in this cohort is crucial for guiding clinical care and future research.

Purpose of the Study:

  • To compare respiratory health, lung function, and airway responsiveness changes between 18 and 25 years of age in young adults born extremely prematurely and term-born controls.
  • To identify potential long-term pulmonary sequelae in individuals born extremely preterm.

Main Methods:

  • A population-based cohort study in western Norway (1982-1985) assessed 25-year-old extremely preterm-born individuals and matched term-born controls.
  • Comprehensive lung function tests and interviews were conducted, comparing data to assessments at 18 years of age.

Main Results:

  • At 25 years, extremely preterm-born individuals had significantly reduced FEV1, FEV1/FVC, and increased airway resistance compared to controls.
  • Increased methacholine responsiveness and bronchial lability were observed in the extremely preterm group.
  • Changes in lung function and respiratory symptoms from 18 to 25 years were similar between groups.

Conclusions:

  • The majority of extremely preterm-born young adults exhibit lung function within the normal range.
  • However, heightened airway responsiveness to methacholine suggests a persistent vulnerability.
  • Continued pulmonary monitoring is advised for individuals born extremely prematurely to manage potential respiratory issues.
Abstract

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
768
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
691
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K